PD-1 Blocker Safe in Childhood Cancers. But Does It Work?
- OPACC
- Mar 19, 2020
- 1 min read
PD-1-directed immunotherapy was safe and tolerable in children and adolescents with previously treated cancers, though responses were limited to those with lymphoma, a phase I/II study found.
Comments